Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrclinonc.2018.27
10.1038/nrclinonc.2018.27 · External reference
Immunotherapy of melanoma
2018 · External reference
Correlate tumor mutation burden with immune signatures in human cancers
10.1186/s12865-018-0285-5 · 2019 · External reference
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
10.1038/s41467-019-14218-7 · 2020 · External reference
10.1158/1535-7163.mct-14-0983
10.1158/1535-7163.mct-14-0983 · External reference
10.1056/nejmoa1500596
10.1056/nejmoa1500596 · External reference
10.1126/science.aaa1348
10.1126/science.aaa1348 · External reference
10.1053/j.seminoncol.2015.05.011
10.1053/j.seminoncol.2015.05.011 · External reference
Classification of triple-negative breast cancers based on Immunogenomic profiling
2018 · External reference
10.1016/j.omto.2020.03.021
10.1016/j.omto.2020.03.021 · External reference
10.1016/j.cell.2015.05.044
10.1016/j.cell.2015.05.044 · External reference
10.18632/oncotarget.3655
10.18632/oncotarget.3655 · External reference
10.1038/s41586-019-1914-8
10.1038/s41586-019-1914-8 · External reference
10.1172/jci.insight.92102
10.1172/jci.insight.92102 · External reference
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma
10.1038/jid.2012.283 · 2013 · External reference
Network-based biomarkers enhance classical approaches to prognostic gene expression signatures
10.1186/1752-0509-8-s4-s5 · 2014 · External reference
10.1126/science.aad0095
10.1126/science.aad0095 · External reference
10.1016/j.cell.2016.02.065
10.1016/j.cell.2016.02.065 · External reference
10.1158/2326-6066.cir-16-0019
10.1158/2326-6066.cir-16-0019 · External reference
10.1016/j.cell.2017.09.028
10.1016/j.cell.2017.09.028 · External reference
10.1056/nejmoa1406498
10.1056/nejmoa1406498 · External reference
10.1200/jco.2012.44.3762
10.1200/jco.2012.44.3762 · External reference
10.1126/science.aad0501
10.1126/science.aad0501 · External reference
10.1038/nprot.2014.006
10.1038/nprot.2014.006 · External reference
10.1186/1471-2105-14-7
10.1186/1471-2105-14-7 · External reference
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
10.1186/s40425-018-0367-1 · 2018 · External reference
10.1038/ncomms3612
10.1038/ncomms3612 · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
10.1093/nar/gkw1092
10.1093/nar/gkw1092 · External reference
10.1186/1471-2105-9-559
10.1186/1471-2105-9-559 · External reference
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
10.1186/gb-2011-12-4-r41 · 2011 · External reference
10.1016/j.celrep.2018.03.076
10.1016/j.celrep.2018.03.076 · External reference
Controlling the false discovery rate: a practical and powerful approach to multiple testing
10.1111/j.2517-6161.1995.tb02031.x · 1995 · External reference
10.1016/j.tranon.2018.07.012
10.1016/j.tranon.2018.07.012 · External reference
10.1016/j.csbj.2019.07.009 · Admitted local publication
10.1016/j.tranon.2018.01.011
10.1016/j.tranon.2018.01.011 · External reference
10.1016/j.fsi.2005.12.008
10.1016/j.fsi.2005.12.008 · External reference
10.1016/j.cca.2020.10.030
10.1016/j.cca.2020.10.030 · External reference
10.1126/science.aaf8399
10.1126/science.aaf8399 · External reference
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
10.1038/s41467-019-12159-9 · 2019 · External reference
10.1016/j.ebiom.2019.03.068
10.1016/j.ebiom.2019.03.068 · External reference
10.1158/0008-5472.can-17-3139
10.1158/0008-5472.can-17-3139 · External reference
10.1016/j.celrep.2017.11.052
10.1016/j.celrep.2017.11.052 · External reference
10.1242/jcs.026393
10.1242/jcs.026393 · External reference
10.1038/nature23465
10.1038/nature23465 · External reference
An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles
2020 · External reference
Cutaneous melanoma and the immunotherapy revolution (Review)
10.3892/ijo.2020.5088 · 2020 · External reference
10.1038/ni.f.220
10.1038/ni.f.220 · External reference
10.1073/pnas.1818210116
10.1073/pnas.1818210116 · External reference
